All infants and children aged <2 years are strongly recommended to receive MenB vaccine. Bexsero is the only MenB vaccine that can be used in infants and children aged <10 years. 

The number of doses required depends on the age of the child when they start the vaccine course.

Table. Recommendations for immunisation of infants and children aged <2 years using meningococcal B vaccine

Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease.

Age at start of vaccine course

MenB vaccine brand

Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease)

6 weeks to 5 months

Bexsero

3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later)

6–11 months

Bexsero

3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later)

12–23 months

Bexsero

2 doses (8 weeks between doses)

Page history

Last updated: 
8 June 2018
Last reviewed: 
8 June 2018